Skip to content
MirrorFirm

Which licence questions should agent developers resolve before using a generated release?

Licence discussions should distinguish training, evaluation, modification and redistribution so the agreed use matches how an agent development team actually works.

**Does access to a sample establish rights for every development use?**

A buyer should confirm the permissions that apply to that sample and to any subsequent release. Do not infer training, redistribution or publication rights from the ability to download the material.

**Which uses should we describe?**

State whether the team intends to train models, run internal evaluations, modify tasks, create derived datasets or share material with contractors. Also describe whether case text, tool traces or generated records could appear in demonstrations, published results or customer-facing products.

**What about copies in development systems?**

Ask how the proposed licence addresses repositories, experiment stores, backups and hosted development services. These locations can retain material beyond the active pilot, so the intended handling should be clear before ingestion.

**Does generated output remove the need for review?**

No. The commercial material is generated, but buyers should still inspect its grounding and disclosure risk. Rights to use the release and suitability for a particular deployment are separate questions. The useful first step is a written description of intended uses for agreement, without assuming terms that have not been offered.

Clarify intended usage and distribution paths before generated material enters development pipelines or externally shared artefacts.

Audience:
Agent developers
Content type:
FAQ
Buyer question:
Scope and getting started

Content release: r-a220eb6e099b243b

More on Periodic review